Protective effects of antioxidants and anti-inflammatory agents against manganese-induced oxidative damage and neuronal injury

Toxicology and Applied Pharmacology

Volumn 256, Issue 3, 2011, Pages 219-226

  Milatovic, Dejan ^a   Gupta, Ramesh C ^b   Yu, Yingchun ^a   Zaja Milatovic, Snjezana ^a   Aschner, Michael ^a,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MURRAY STATE UNIVERSITY   (United States)

^c Research on Human Development   (United States)

Author keywords

Ibuprofen; Manganese; Medium spiny neurons; Neurodegeneration; Oxidative stress; Trolox; Vitamin E

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA TOCOPHEROL; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; BIOLOGICAL MARKER; IBUPROFEN; INDOMETACIN; ISOPROSTANE; MANGANESE; PHOSPHATE; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; TROLOX C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CELL; BRAIN NERVE CELL; COMPUTER PROGRAM; CONTROLLED STUDY; DENDRITIC CELL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFECT; FEMALE; GOLGI COMPLEX; MEDIUM SPINY NEURON; MOUSE; NERVE CELL LESION; NEUROLUCIDA; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PROTEIN DEPLETION; SYNAPSE;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CELLS, CULTURED; CEREBRUM; CHROMANS; DINOPROSTONE; F2-ISOPROSTANES; FEMALE; IBUPROFEN; INDOMETHACIN; MANGANESE POISONING; MICE; MICE, INBRED C57BL; NEURONS; NEUROTOXICITY SYNDROMES; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES;

MUS; RATTUS;

EID: 80855148194     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.06.001     Document Type: Article

References (73)

1. Asanuma M., Nishibayashi-Asanuma S., Miyazaki I., Kohno M. Neuroprotective effects of non-steroidal anti-inflammatory drugs by direct scavenging of nitric oxide radicals. J. Neurochem. 2001, 76:1895-1904.
2. Aschner M. Manganese in health and disease: from transport to neurotoxicity. Handbook of neurotoxicology 2000, 195-209. Humana Press, Totowa, NJ. E. Massaro (Ed.).
3. Autissier N., Rochette L., Dumas P., Beley A., Loireau A., Bralet J. Dopamine and norepinephrine turnover in various regions of the rat brain after chronic manganese chloride administration. Toxicology 1982, 24:175-182.
4. Avila D.S., Colle D., Gubert P., Palma A.S., Puntel G., Manarin F., Noremberg S., Nascimento P.C., Aschner M., Rocha J.B., Soares F.A. A possible neuroprotective action of a vinylic telluride against Mn-induced neurotoxicity. Toxicol. Sci. 2010, 115:194-201.
5. Awas J.A., Soteriou M.C., Drougas J.G., Stokes K.A., Roberts L.J., Pinson C.W. Plasma prostaglandin E1 concentrations and hemodynamics during intravenous infusions of prostaglandin E1 in humans and swine. Transplantation 1996, 61:1624-1629.
6. Barclay L.R., Vinqvist M.R. Membrane peroxidation: inhibiting effects of water-soluble antioxidants on phospholipids of different charge types. Free Radic. Biol. Med. 1994, 16:779-788.
7. Boldyrev A.A., Carpenter D.O., Huentelman M.J., Peters C.M., Johnson P. Sources of reactive oxygen species production in excitotoxin-stimulated cerebellar granule cells Biochem. Biophys. Res. Commun. 1999, 256:320-324.
8. Bolte S., Normandin L., Kennedy G., Zayed J. Human exposure to respirable manganese in outdoor and indoor air in urban and rural areas. J. Toxicol. Environ. Health A. 2004, 67:459-467.
9. Bowler R.M., Nakagawa S., Drezgic M., Roels H.A., Park R.M., Diamond E., et al. Sequelae of fume exposure in confined space welding: a neurological and neuropsychological case series. Neurotoxicology 2007, 28:298-311.
10. Brouillet E.P., Shinobu L., McGarvey U., Hochberg F., Beal M.F. Manganese injection into the rat striatum produces excitotoxic lesions by impairing energy metabolism. Exp. Neurol. 1993, 120:89-94.
11. Cersosimo M.G., Koller W.C. The diagnosis of manganese induced parkinsonism. Neurotoxicology 2006, 27:340-346.
12. Defazio G., Soleo L., Zefferino R., Livrea P. Manganese toxicity in serumless dissociated mesencephalic and striatal primary culture. Brain Res. Bull. 1996, 40:257-262.
13. Deutch A.Y., Colbran R.J., Winder D.J. Striatal plasticity and medium spiny neuron dendritic remodeling in parkinsonism. Parkinsonism Relat. Disord. 2007, 13(Suppl. 3):S251-S258.
14. Dobson A.W., Erikson K.M., Aschner M. Manganese neurotoxicity. Ann. N.Y Acad. Sci. 2004, 1012:115-128.
15. Dodd C.A., Ward D.L., Klein B.G. Basal ganglia accumulation and motor assessment following manganese chloride exposure in the C57Cl/6 mouse. Int. J. Toxicol. 2005, 24:389-397.
16. Dorman D.C., Struve M.F., Clewell H.J., Andersen M.E. Application of pharmacokinetic data to the risk assessment of inhaled manganese. Neurotoxicology 2006, 27:752-764.
17. Erikson K.M., Dorman D.C., Lash L.H., Aschner M. Manganese inhalation by rhesus monkeys is associated with brain regional changes in biomarkers of neurotoxicity. Toxicol. Sci. 2007, 97:459-466.
18. Fang Y.Z., Yang S., Guoyao W. Free radicals, antioxidant, and nutrition. Nutrition 2002, 18:872-879.
19. Filipov N.M., Seegal R.F., Lawrence D.A. Manganese potentiates in vitro production of proinflammatory cytokines and nitric oxide by microglia through a nuclear factor kappa B-dependent mechanism. Toxicol. Sci. 2005, 84:139-148.
20. Frankel E.N. Antioxidants. Lipid Oxidation 2005, 209-258. The Oily Press, Bridgwater, United Kingdom. E.N. Frankel (Ed.).
21. Gavin C.E., Gunter K.K., Gunter T.E. Manganese and calcium efflux kinetics in brain mitochondria. Relevance to manganese toxicity. Biochem. J. 1990, 266:329-334.
22. 2+ sequestration by mitochondria and inhibition of oxidative phosphorylation. Toxicol. Appl. Pharmacol. 1992, 1992(115):1-5.
23. Green D.R., Reed J.C. Mitochondria and Apoptosis. Science 1998, 281:1309-1312.
24. Greenamyre J.T., MacKenzie G., Peng T.I., Stephans S.E. Mitochondrial dysfunction in Parkinson's disease. Biochem. Soc. Symp. 1999, 66:85-97.
25. Guilarte T.R., Chen M.K. Manganese inhibits NMDA receptor channel function: implications to psychiatric and cognitive effects. Neurotoxicology 2007, 28:1147-1152.
26. Gunter T.E., Gavin C.E., Aschner M., Gunter K.K. Speciation of manganese in cells and mitochondria: a search for the proximal cause of manganese neurotoxicity. Neurotoxicology 2006, 27:765-776.
27. Hazell A.S., Normandin L., Norenberg M.D., Kennedy G., Yi J.H. Alzheimer type II astrocytic changes following sub-acute exposure to manganese and its prevention by antioxidant treatment. Neurosci. Lett. 2006, 396:167-171.
28. Iinuma Y., Kubota M., Uchiyama M., Yagi M., Kanada S., Yamazaki S., Murata H., Okamoto K., Suzuki M., Nitta K. Whole-blood manganese levels and brain manganese accumulation in children receiving long-term home parenteral nutrition. Pediatr. Surg. Int. 2003, 19:268-272.
29. Im J.Y., Kim D., Paik S.G., Han P.L. Cyclooxygenase-2-dependent neuronal death proceeds via superoxide anion generation. Free Radic. Biol. Med. 2006, 41:960-972.
30. Kaur P., Evje L., Aschner M., Syversen T. The in vitro effects of Trolox on methylmercury-induced neurotoxicity. Toxicology 2010, 276:73-78.
31. Kitazawa M., Anantharam V., Yang Y., Hirata Y., Kanthasamy A., Kanthasamy A.G. Activation of protein kinase Cδ by proteolytic cleavage contributes to manganese-induced apoptosis in dopaminergic cells: protective role of Bcl-2. Biochem. Pharmacol. 2005, 69:133-146.
32. Komura J., Sakamoto M. Effects of manganese forms on biogenic amines in the brain and behavioral alterations in the mouse: long-term oral administration of several manganese compounds. Environ. Res. 1992, 57:34-44.
33. 31 P-NMR using a Langendorff perfusion technique. J. Mol. Cell. Cardiol. 1993, 25:1067-1074.
34. Latchoumycandane C., Anantharam V., Kitazawa M., Yang Y., Kanthasamy A., Kanthasamy A.G. Protein kinase Cdelta is a key downstream mediator of manganese-induced apoptosis in dopaminergic neuronal cells. J. Pharmacol. Exp. Ther. 2005, 1(313):46-55.
35. Leuner B., Falduto J., Shors T. Associative memory formation increases the observation of dendritic spines in the hippocampus. J. Neurosci. 2003, 23:659-665.
36. Liu B., Gao H.M., Hong J.S. Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation. Environ. Health Perspect. 2003, 111:1065-1073.
37. Lucchini R.G., Martin C.J., Doney B.C. From manganism to manganese-induced parkinsonism: conceptual model based on the evolution of exposure. Neuromol. Med. 2009, 11:311-321.
38. Marnett L.J., Rowlinson S.W., Goodwin D.C., Kalgutkar A.S., Lanzo C.A. Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition. J. Biol. Chem. 1999, 274:22903-22906.
39. Massey K.D., Burton K.P. Free radical damage in neonatal rat cardiac myocyte cultures: effects of alpha-tocopherol, Trolox and phytol. Free Radic. Biol. Med. 1990, 8:449-458.
40. Mergler D., Huel G., Bowler R., Iregren A., Belanger S., Baldwin M., et al. Nervous system dysfunction among workers with long-term exposure to manganese. Environ. Res. 1994, 64:151-180.
41. Milatovic D., Aschner M. Measurement of isoprostanes as markers of oxidative stress in neuronal tissue. Curr. Protoc. in Toxicol. unit 2009, 12(14):1-12.
42. Milatovic D., Zaja-Milatovic S., Montine K.S., Horner P.J., Montine T.J. Pharmacologic suppression of neuronal oxidative damage and dendritic degeneration following direct activation of glial innate immunity in mouse cerebrum. J. Neurochem. 2003, 87:1518-1526.
43. Milatovic D., Milatovic S., Montine K., Shie F.S., Montine T.J. Neuronal oxidative damage and dendritic degeneration following activation of CD14-dependent innate immunity response in vivo. J. Neuroinflammation 2004, 1(20):1-7.
44. 4-neuroprostanes from excitotoxicity and innate immune response in vivo by alpha- or gamma-tocopherol. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2005, 827:88-93.
45. Milatovic D., Yin Z., Gupta R.C., Sydoryk M., Albrecht J., Aschner J.L., Aschner M. Manganese induces oxidative impairment in cultured rat astrocytes. Toxicol. Sci. 2007, 98:198-205.
46. Milatovic D., Zaja-Milatovic S., Gupta R.C., Yu Y., Aschner M. Oxidative damage and neurodegeneration in manganese-induced neurotoxicity. Toxicol. Appl. Pharmacol. 2009, 240:219-225.
47. 2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Methods Enzymol. 1999, 300:3-12.
48. Onodera K., Omoi N.O., Fukui K., Hayasaka T., Shinkai T., Suzuki S., Abe K., Urano S. Oxidative damage of rat cerebral cortex and hippocampus, and changes in antioxidative defense systems caused by hyperoxia. Free. Radic. Res. 2003, 37:367-372.
49. Perl D.P., Olanow C.W. The neuropathology of manganese-induced Parkinsonism. J. Neuropathol. Exp. Neurol. 2007, 66:675-682.
50. Punz A., Nanobashvili N., Feugl A., et al. Effect of α-tocopherol pretreatment on high energy metabolites in rabbit skeletal muscle after ischemia-reperfusion. Clin. Nutr. 1998, 17:85-87.
51. Racette B.A., McGee-Minnich L., Moerlein S.M., Mink J.W., Videen T.O., Perlmutter J.S. Welding-related parkinsonism: clinical features, treatment, and pathophysiology. Neurology 2001, 56:8-13.
52. Raspor P., Pleniscar S., Gazdag Z., Pesti M., Miklavcic M., Lah B., Logar-Marinsek R., Poljsak B. Prevention of intracellular oxidation in yeast: the role of vitamin E analogue, Trolox (6-hydroxy-2,5,7,8-tetramethylkroman-2-carboxyl acid). Cell Biol. Int. 2005, 29:57-63.
53. Rauca C., Wiswedel I., Zerbe R., Keilhoff G., Krug M. The role of superoxide dismutase and alpha-tocopherol in the development of seizures and kindling induced by pentylenetetrazol-influence of the radical scavenger alpha-phenyl-N-tert-butylnitrone. Brain Res. 2004, 1009:203-212.
54. Sagach V.F., Scrosati M., Fielding J., Rossoni G., Galli C., Visioli F. The water-soluble vitamin E analogue Trolox protects against ischaemia/reperfusion damage in vitro and ex vivo. A comparison with vitamin E. Pharmacol. Res. 2002, 45:435-439.
55. Shinotoh H., Snow B.J., Chu N.S., Huang C.C., Lu C.S., Lee C., Takahashi H., Calne D.B. Presynaptic and postsynaptic striatal dopaminergic function in patients with manganese intoxication: a positron emission tomography study. Neurology 1997, 48:1053-1056.
56. Sloot W.N., van der Sluijs-Gelling A.J., Gramsbergen J.B.P. Selective lesions by manganese and extensive damage by iron after injection into rat striatum or hippocampus. J. Neurochem. 1994, 62:205-216.
57. Suzuki Y., Mouri T., Suzuki Y., Nishiyama K., Fujii N. Study of subacute toxicity of manganese dioxide in monkeys. Tokushima J. Exp. Med. 1975, 22:5-10.
58. Takeda A. Manganese action in brain function. Brain Res. Rev. 2003, 41:79-87.
59. Tansey M.G., McCoy M.K., Frank-Cannon T.C. Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention Exp. Neurol. 2007, 1(208):1-25.
60. Turrens J.F., Boveris A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem. J. 1980, 191:421-427.
61. Usuki F., Yasutake A., Umehara F., Tokunaga H., Matsumoto M., Eto K., Ishiura S., Higuchi I. In vivo protection of a water-soluble derivative of vitamin E, Trolox, against methylmercury-intoxication in the rat. Neurosci. Lett. 2001, 304:199-203.
62. VanAcker S.A.B.E., Koymans L.M.H., Bast A. Molecular pharmacology of vitamin E: structural aspects of antioxidant activity. Free Radic. Biol. Med. 1993, 15:311-328.
63. Weggen S., Eriksen J.L., Das P., Sagi S.A., Wang R., Pietzik C.U., Findlay K.A., Smith T.E., Murphy M.P., Butler T., Kang D.E., Sterling N., Golde T.E., Koo E.H. A subset of NSAIDs lower amyloidogenic A[beta]42 independently of cyclo-oxygenase activity. Nature 2001, 414:212-216.
64. Wilson P., Groves P.M. Fine structure and synaptic connections of the common spiny neuron of the rat neostriatum: a study employing intracellular inject of horseradish peroxidase. J. Comp. Neurol. 1980, 194:599-615.
65. Wu T.W., Hashimoto N., Wu J., Carey D., Li R.K., Mickle D.A., Weisel R.D. The cytoprotective effect of Trolox demonstrated with three types of human cells. Biochem. Cell Biol. 1990, 68:1189-1194.
66. Yang M.S., Yu L.C., Gupta R.C. Analysis of changes in energy and redox states in HepG2 hepatoma and C6 glioma cells upon exposure to cadmium. Toxicology 2004, 201:105-113.
67. Zaja-Milatovic S., Milatovic D., Schantz A., Zhang J., Montine K., Montine T.J. Dendritic degeneration in neostriatal medium spiny neurons in late-stage Parkinson disease. Neurology 2005, 64:545-547.
68. Zaja-Milatovic S., Gupta R.C., Aschner M., Montine T.J., Milatovic D. Pharmacologic suppression of oxidative damage and dendritic degeneration following kainic acid-induced excitotoxicity in mouse cerebrum. Neurotoxicology 2008, 29(4):621-627.
69. Zaja-Milatovic S., Gupta R.C., Aschner M., Milatovic D. Protection of DFP-induced oxidative damage and neurodegeneration by antioxidants and NMDA receptor antagonist. Toxicol. Appl. Pharmacol. 2009, 240:124-131.
70. Zhang S., Fu J., Zhou Z. In vitro effect of manganese chloride exposure on reactive oxygen species generation and respiratory chain complexes activities of mitochondria isolated from rat brain. Toxicol. In Vitro 2004, 18:71-77.
71. Zhang P., Wong T.A., Lokuta K.M., Turner D.E., Vujisic K., Liu B. Microglia enhance manganese chloride-induced dopaminergic neurodegeneration: role of free radical generation. Exp. Neurol. 2009, 217:219-230.
72. Zhang P., Lokuta K.M., Turner D.E., Liu B. Synergistic dopaminergic neurotoxicity of manganese and lipopolysaccharide: differential involvement of microglia and astroglia. J. Neurochem. 2010, 112:434-443.
73. Zhao F., Cai T., Liu M., Zheng G., Luo W., Chen J. Manganese induces dopaminergic neurodegeneration via microglial activation in a rat model of manganism. Toxicol. Sci. 2009, 107:156-164.